Target Name: IDSP1
NCBI ID: G3424
Other Name(s): iduronate 2-sulfatase pseudogene 1 | IDS2 | Iduronate 2-sulfatase pseudogene 1

IDSP1: Potential Drug Targets for Cancer and Neurodegenerative Diseases

IDSP1 (iduronate 2-sulfatase pseudogene 1) is a gene that encodes a protein known as IDURONATE2SULFATASE. This protein is involved in the breakdown of iduronate, a compound that is found in many foods, including whole grains, legumes, and vegetables. IDURONATE2SULFATASE is a key enzyme in the iduronate pathway, which is involved in the breakdown of this compound and the production of other molecules that are important in cellular signaling.

The iduronate pathway is a complex process that involves the breakdown of iduronate by IDURONATE2SULFATASE, which is located in the cytoplasm. This enzyme is responsible for breaking down the iduronate molecule into the simpler compound, iduronate monosulfate, which is then transported into the mitochondria, where it is involved in the production of other molecules, including ATP and gamma-aminobutyric acid (GABA).

IDSP1 gene

The IDSP1 gene is located on chromosome X chromosome and has been identified as a potential drug target or biomarker. The IDSP1 gene has been shown to be involved in a variety of cellular processes, including the regulation of cell growth, differentiation, and metabolism.

One of the functions of IDSP1 is to regulate the activity of the gene encoding the activating transcription factor (ATF) receptor, which is a protein that plays a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation. This gene has been shown to be involved in the regulation of cell growth and the development of cancer.

Another function of IDSP1 is to regulate the activity of the gene encoding the tumor suppressor protein TP53, which is a protein that plays a role in the regulation of cell growth and apoptosis. This gene has been shown to be involved in the regulation of cell growth and the development of cancer, and may be a potential drug target for cancer therapies.

IDSP1 and diseases

IDSP1 has been shown to be involved in a variety of diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

One of the potential applications of IDSP1 as a drug target is its role in the treatment of cancer. IDSP1 has been shown to be involved in the regulation of cell growth and the development of cancer, and may be a potential target for therapies that target these processes. For example, studies have shown that inhibiting the activity of IDSP1 may be an effective way to inhibit the growth of cancer cells.

Another potential application of IDSP1 as a drug target is its role in the treatment of neurodegenerative diseases. IDSP1 has been shown to be involved in the regulation of cellular processes that are important in the development of neurodegenerative diseases. For example, studies have shown that inhibiting the activity of IDSP1 may be an effective way to treat neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.

IDSP1 has also been shown to be involved in the regulation of metabolism and cellular processes that are important in a variety of metabolic disorders. For example, studies have shown that inhibiting the activity of IDSP1 may be an effective way to treat diseases such as diabetes and obesity.

Conclusion

In conclusion, IDSP1 (iduronate 2-sulfatase pseudogene 1) is a gene that encodes a protein involved in the iduronate pathway. This pathway is involved in the breakdown of iduronate, a compound that is found in many foods, and the production of other molecules that are important in cellular signaling. IDSP1 has been shown to be involved in a variety of cellular processes, including the regulation of cell growth, differentiation, and metabolism, as well as the regulation of the activating transcription factor (ATF) receptor and the tumor suppressor protein TP53. As a result, IDSP1 is a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Further research is needed to fully understand the role of IDSP1 in these processes and to develop effective therapies that target this gene.

Protein Name: Iduronate 2-sulfatase Pseudogene 1

More Common Targets

IDUA | IER2 | IER3 | IER3-AS1 | IER3IP1 | IER5 | IER5L | IER5L-AS1 | IFFO1 | IFFO2 | IFI16 | IFI27 | IFI27L1 | IFI27L2 | IFI30 | IFI35 | IFI44 | IFI44L | IFI6 | IFIH1 | IFIT1 | IFIT1B | IFIT2 | IFIT3 | IFIT5 | IFITM1 | IFITM10 | IFITM2 | IFITM3 | IFITM3P2 | IFITM3P7 | IFITM4P | IFITM5 | IFITM8P | IFITM9P | IFNA1 | IFNA10 | IFNA12P | IFNA13 | IFNA14 | IFNA16 | IFNA17 | IFNA2 | IFNA21 | IFNA22P | IFNA4 | IFNA5 | IFNA6 | IFNA7 | IFNA8 | IFNAR1 | IFNAR2 | IFNB1 | IFNE | IFNG | IFNG-AS1 | IFNGR1 | IFNGR2 | IFNK | IFNL1 | IFNL2 | IFNL3 | IFNL4 | IFNLR1 | IFNW1 | IFNWP15 | IFNWP19 | IFRD1 | IFRD2 | IFT122 | IFT122P3 | IFT140 | IFT172 | IFT20 | IFT22 | IFT27 | IFT43 | IFT46 | IFT52 | IFT57 | IFT74 | IFT80 | IFT81 | IFT88 | IFTAP | IGBP1 | IGBP1P1 | IGDCC3 | IGDCC4 | IgE Receptors | IGF1 | IGF1R | IGF2 | IGF2-AS | IGF2BP1 | IGF2BP2 | IGF2BP2-AS1 | IGF2BP3 | IGF2R | IGFALS